Search Results - "MAIORINO, L."

The role of post‐natal ontogeny in the evolution of phenotypic diversity in Podarcis lizards by PIRAS, P., SALVI, D., FERRARA, G., MAIORINO, L., DELFINO, M., PEDDE, L., KOTSAKIS, T.

“…Understanding the role of the developmental pathways in shaping phenotypic diversity allows appreciating in full the processes influencing and constraining…”
Get full text

A nomogram to predict poor health-related quality of life in metastatic colorectal cancer patients by Formica, V., Nardecchia, A., Morelli, C., Lucchetti, J., Giuliano, G., Renzi, N., Gallo, C., Serci, C., Pellegrino, R., Massimiliani, V., Maiorino, L., Roselli, M.

Get full text

Pequeños vertebrados del relleno kárstico del Pleistoceno Superior de Avetrana (Apulia, Sur de Italia) by Kotsakis, T., Pandolfi, L., Maiorino, L., Petronio, C., Sansalone, G., Salari, L.

“…El depósito (cavidad kárstica) de La Grave, localidad cercana a la pequeña ciudad de Avetrana (Tarento, Italia meridional), ha dado lugar a numerosos fósiles…”
Get full text

Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial by Mustacchi, G., Ceccherini, R., Milani, S., Pluchinotta, A., De Matteis, A., Maiorino, L., Farris, A., Scanni, A., Sasso, F.

“…Background: To evaluate the efficacy of tamoxifen as primary treatment in women aged over 70 years with operable breast cancer versus surgery followed by…”
Get full text

2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian “real life” study by Giordano, G, Febbraro, A, Vaccaro, V, Zagonel, V, De Giorgi, U, Melisi, D, Vasile, E, Bianco, R, Lo Re, G, Valente, M, Formica, V, Montesarchio, V, Maiorino, L, Sanna, G, Bittoni, A, Ricci, V, Santini, D, Zaniboni, A, Milella, M, De Vita, F

Get full text

Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101) by Comella, P., Filippelli, G., De Cataldis, G., Massidda, B., Frasci, G., Maiorino, L., Putzu, C., Mancarella, S., Palmeri, S., Cioffi, R., Roselli, M., Buzzi, F., Milia, V., Gambardella, A., Natale, D., Bianco, M., Ghiani, M., Masullo, P.

“…Background: Triplet regimens were occasionally reported to produce a higher response rate (RR) than doublets in locally advanced or metastatic non-small-cell…”
Get full text

Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients by COMELLA, P, FRASCI, G, CIOFFI, R, CARNICELLI, P, MASSIDDA, B, BUZZI, F, FILIPPELLI, G, MAIORINO, L, GUIDA, M, PANZA, N, MANCARELLA, S

“…The aim of this study was to assess whether a combination of gemcitabine (GEM) with either paclitaxel (PTX) or vinorelbine (VNR) could be more effective than…”
Get full text

Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial by Comella, P., Massidda, B., Filippelli, G., Palmeri, S., Natale, D., Farris, A., De Vita, F., Buzzi, F., Tafuto, S., Maiorino, L., Mancarella, S., Leo, S., Lorusso, V., De Lucia, L., Roselli, M.

“…Purpose:: The primary end point of this phase III trial was to compare the response rate (RR) of oxaliplatin (OXA) plus levo-folinic acid (l-FA) and…”
Get full text

P315 Acceptance and adherence with oral endocrine therapy in women with metastatic breast cancer: ExaCampania group study by Addeo, R, Russo, P, Maiorino, L, Febraro, A, Leo, L, Incoronato, P, Pisano, A, Bianco, M, Mabilia, R, del Prete, S

Get full text

785 SORAFENIB PLUS OCTREOTIDE IN ADVANCED HEPATOCELLULAR CARCINOMA: UPDATED RESULTS OF A MULTICENTER STUDY by Del Prete, S, Addeo, R, Caraglia, M, Maiorino, L, Montesarchio, V, Cennamo, G, Guarrasi, R, Faiola, V, Leo, L, Febbraro, A, Vincenzi, B, Savastano, C, Tarantino, L, Sabia, A, Capasso, E, Palmieri, G, Giorgio, A, Bianco, M, Montella, L

Get full text

Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma by COMELLA, P, FARRIS, A, LORUSSO, V, PALMERI, S, MAIORINO, L, DE LUCIA, L, BUZZI, F, MANCARELLA, S, DE VITA, F, GAMBARDELLA, A

“…The aim of this study was to assess the safety and efficacy of biweekly irinotecan plus leucovorin-modulated 5-fluorouracil i.v. bolus in metastatic colorectal…”
Get full text

Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients : a Southern Italy Cooperative Oncology Group phase II study by COMELLA, P, MASSIDDA, B, PALMERI, S, FARRIS, A, DE LUCIA, L, NATALE, D, MAIORINO, L, TAFUTO, S, DE CATALDIS, G, CASARETTI, R

“…Oxaliplatin 100 mg/m(2) iv on day 1, and capecitabine 1,000 mg/m(2) orally bid from day 1 (evening) to day 11 (morning) were administered every 2 weeks (OXXEL…”
Get full text

Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps by Park, Juwon, Wysocki, Robert W, Amoozgar, Zohreh, Maiorino, Laura, Fein, Miriam R, Jorns, Julie, Schott, Anne F, Kinugasa-Katayama, Yumi, Lee, Youngseok, Won, Nam Hee, Nakasone, Elizabeth S, Hearn, Stephen A, Küttner, Victoria, Qiu, Jing, Almeida, Ana S, Perurena, Naiara, Kessenbrock, Kai, Goldberg, Michael S, Egeblad, Mikala

“…Neutrophils, the most abundant type of leukocytes in blood, can form neutrophil extracellular traps (NETs). These are pathogen-trapping structures generated by…”
Get more information

Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group by Comella, P., Crucitta, E., De Vita, F., De Lucia, L., Farris, A., Del Gaizo, F., Palmeri, S., Iannelli, A., Mancarella, S., Tafuto, S., Maiorino, L., Buzzi, F., De Cataldis, G.

“…Purpose The purpose of this study was to compare the activity and toxicity of the combination of irinotecan (IRI) plus folinic acid (FA)-modulated…”
Get full text

Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study by Del Prete, S, Addeo, R, Maiorino, L, Cennamo, G, Montesarchio, V, Leo, L, Faiola, V, Guarrasi, R, Tarantino, L, Vascone, A, D’Agostino, A, Palmieri, G, Bianco, M, Caraglia, M, Pizza, C, Mamone, R, Montella, L

Get full text

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial by Comella, P, Frasci, G, De Cataldis, G, Panza, N, Cioffi, R, Curcio, C, Belli, M, Bianco, A, Ianniello, G, Maiorino, L, Della Vittoria, M, Perchard, J, Comella, G

Get full text

3044 POSTER Capecitabine or Folinic acid/Fluorouracil i.v. bolus plus Eloxatin evaluation (COFFE trial) in metastatic colorectal carcinoma (MCRC): final results of the Southern Italy Cooperative Oncology Group (SICOG) phase III trial 0401 by Comella, P, Massidda, B, Filippelli, G, Farris, A, Natale, D, Maiorino, L, Condemi, G, Palmeri, S, Leo, S, Gambardella, A

Get full text

P-178A nomogram to predict poor health-related quality of life in metastatic colorectal cancer patients by Formica, V, Nardecchia, A, Morelli, C, Lucchetti, J, Giuliano, G, Renzi, N, Gallo, C, Serci, C, Pellegrino, R, Massimiliani, V, Maiorino, L, Roselli, M

Get full text

Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOQ) phase II study by FRASCI, Giuseppe, D'AIUTO, Giuseppe, D'ANIELLO, Roberta, FREZZA, Pasquale, LAPENTA, Liliana, COMELLA, Giuseppe, COMELLA, Pasquale, THOMAS, Renato, CAPASSO, Immacolata, DI BONITO, Maurizio, RIVELLINI, Flavia, CARTENI, Giacomo, DE LUCIA, Luigi, MAIORINO, Luigi

“…It has been shown in vitro that both cisplatin and epirubicin increase the antitumor activity of paclitaxel. Weekly administration could give a substantial…”
Get full text

Evolution of the sabertooth mandible: A deadly ecomorphological specialization by Piras, Paolo, Silvestro, Daniele, Carotenuto, Francesco, Castiglione, Silvia, Kotsakis, Anastassios, Maiorino, Leonardo, Melchionna, Marina, Mondanaro, Alessandro, Sansalone, Gabriele, Serio, Carmela, Vero, Veronica Anna, Raia, Pasquale

“…Saber-toothed cats were armed with formidable weapons. They evolved a number of highly derived morphological features, most notably a pair of extremely long…”
Get full text